NCT02010047 - Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients | Biotech Hunter

Enrollment

166

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 18, 2015

Study Completion Date

August 18, 2015

Conditions

Nonsmall Cell Lung Cancer

Interventions

DEVICE

ALK qPCR assay

72 IHC ALK-negative and 72 IHC ALK-positive FFPE samples will tested with FISH and qPCR to determine the sensitivity and specificity of the ALK qPCR assay.

Trial Locations (7)

V2S 0C2

BC Cancer Agency-Abbotsford Centre, Abbotsford

V1Y 5L3

BC Cancer Agency-Centre for the Southern Interior, Kelowna

V7L 2L7

Lions Gate Hospital, North Vancouver

V2N 7E9

BC Cancer Agency-Centre for the North, Prince George

V3V 1Z2

BC Cancer Agency, Frase Valley Centre, Surrey

V5Z 4E6

BC Cancer Agency, Vancouver Centre, Vancouver

V8R 6V5

BC Cancer Agency, Victoria